About: Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.20 (-4.02%)
CNTX NASDAQ Context Therapeutics Inc
Context Therapeutics Inc share price
Atividade de preço de CNTX
Último preço
$ 0,200
Variação (24h)
-0,01 USD (4,02%)
Volume
33.09K
Volume (média 4 sem.)
-
Fechamento anterior
$ 0,21
Último negócio
29 Oct, 1:33 pm GMT+0
Atrasado
29 Oct, 1:33 pm GMT+0
CNTX price performance
Atrasado
29 Oct, 1:33 pm GMT+0
quote.marketSignals